Are We There Yet? Another Milepost in the Journey to Identify Appropriate Candidates for Aspirin Primary Prevention

Ann Intern Med. 2019 Mar 19;170(6):411-413. doi: 10.7326/M19-0416. Epub 2019 Feb 26.

Authors

Evelyn P Whitlock¹, Eric S Johnson²

Affiliations

¹ Patient-Centered Outcomes Research Institute, Washington, DC (E.P.W.).
² Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon (E.S.J.).

PMID: 30802898
DOI: 10.7326/M19-0416

No abstract available

Publication types

Editorial
Comment

MeSH terms

Aspirin*
Cardiovascular Diseases*
Cohort Studies
Hemorrhage
Humans
Primary Prevention

Substances

Aspirin